Author: Christa Nuber

Study Shows Hair Cell Regrowth with New Drug

A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women’s Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.

Read More

Phonak US Appoints New Sales Executives

Phonak announced the appointment of Jason Mayer as vice president of commercial sales, and Rose Bongiovanni as vice president of strategic accounts. Mayer brings 13 years of industry experience to his new role, and audiologist Bongiovanni brings more than 30 years in the hearing industry to her new role.

Read More

Signia Receives Two CES 2017 Innovation Awards

Signia has been named a CES 2017 Innovation Awards Honoree for two of its products: the Cellion™ hearing aid and the myHearing app. Products entered in the CES program are judged by a panel of independent industrial designers, engineers, and media to honor outstanding design and engineering.

Read More

Hearing Problems in Schizophrenia Tied to Brain Receptors

The inability to hear subtle changes in pitch, a common and debilitating problem for people with schizophrenia, is due to dysfunctional N-methyl-D-aspartate (NMDA) brain receptors that affect auditory plasticity. Researchers found that this hearing deficit can be improved by combining auditory training exercises with a drug that targets NMDA receptors.

Read More